Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 1.04% | 202.89 | 1.3% | $439.73m | |
| BIIB | Biogen Inc. | 1.14% | 225.76 | 1.3% | $382.28m | |
| GILD | Gilead Sciences, Inc. | 0.81% | 64.51 | 0.9% | $362.26m | |
| CELG | Celgene Corporation | -0.18% | 100.39 | 1.3% | $352.37m | |
| ILMN | Illumina, Inc. | 2.56% | 310.31 | 3.5% | $266.69m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.55% | 305.44 | 2.6% | $219.74m | |
| EXAS | Exact Sciences Corporation | 2.54% | 94.85 | 24.1% | $199.38m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 2.11% | 101.34 | 2.0% | $181.06m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.68% | 173.59 | 1.9% | $178.83m | |
| A | Agilent Technologies, Inc. | -0.16% | 75.18 | 1.6% | $153.77m | |
| SRPT | Sarepta Therapeutics, Inc. | 2.66% | 85.70 | 14.6% | $141.72m | |
| ALDR | Alder Biopharmaceuticals, Inc. | 0.27% | 18.92 | 10.2% | $132.33m | |
| BMRN | BioMarin Pharmaceutical Inc. | -0.18% | 67.24 | 4.3% | $95.95m | |
| ACAD | ACADIA Pharmaceuticals Inc. | -2.57% | 39.48 | 13.4% | $89.57m | |
| SGEN | Seattle Genetics, Inc. | -0.22% | 82.42 | 6.2% | $84.75m |
Company Profile
Retrophin, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. Its products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 8, 2008 and is headquartered in San Diego, CA.